Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Galectin Therapeutics Inc..
Galectin Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Galectin Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Galectin Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Galectin Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Galectin Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Galectin Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Galectin Therapeutics Inc.- Key Facts
2.2 Galectin Therapeutics Inc.- Geographic Locations
2.3 Galectin Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Galectin Therapeutics Inc.- Business Divisions
2.5 Galectin Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Galectin Therapeutics Inc. Strategic Analysis Review
3.1 Galectin Therapeutics Inc.- Key Strategies
3.2 Galectin Therapeutics Inc.- Company Outlook Statement
3.3 Galectin Therapeutics Inc.- SWOT Analysis
3.3.1 Galectin Therapeutics Inc.- Key Strengths
3.3.2 Galectin Therapeutics Inc.- Key Weaknesses
3.3.3 Galectin Therapeutics Inc.- Potential Opportunities
3.3.4 Galectin Therapeutics Inc.- Potential Threats
3.4 Galectin Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Galectin Therapeutics Inc.- Business Overview
4.2 Galectin Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Galectin Therapeutics Inc.- Key Products
5.2 Galectin Therapeutics Inc.- Key Service Areas
5.3 Galectin Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Galectin Therapeutics Inc.- Company History
6.2 Galectin Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Galectin Therapeutics Inc.- Income Statements
7.2 Galectin Therapeutics Inc.- Balance Sheet
7.3 Galectin Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Galectin Therapeutics Inc.- Direct Competitors
8.2 Galectin Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Galectin Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Galectin Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!